Slow release oral morphine versus methadone for the treatment of opioid use disorder.
dc.contributor.author | Klimas, Jan | |
dc.contributor.author | Gorfinkel, Lauren | |
dc.contributor.author | Giacomuzzi, Salvatore M | |
dc.contributor.author | Ruckes, Christian | |
dc.contributor.author | Socías, M Eugenia | |
dc.contributor.author | Fairbairn, Nadia | |
dc.contributor.author | Wood, Evan | |
dc.date.accessioned | 2019-04-23T14:22:46Z | |
dc.date.available | 2019-04-23T14:22:46Z | |
dc.date.issued | 2019-04-02 | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.pmid | 30944135 | |
dc.identifier.doi | 10.1136/bmjopen-2018-025799 | |
dc.identifier.uri | http://hdl.handle.net/10147/624158 | |
dc.description.abstract | Two independent reviewers extracted data and assessed risk of bias. Data were pooled using the random-effects model and expressed as risk ratios (RRs) or mean differences with 95% CIs. Heterogeneity was assessed (χ2 statistic) and quantified (I2 statistic) and a sensitivity analysis was undertaken to assess the impact of particular high-risk trials. | |
dc.language.iso | en | en_US |
dc.subject | meta-analysis | en_US |
dc.subject | opioid use disorder | en_US |
dc.subject | oral morphine | en_US |
dc.subject | substance misuse | en_US |
dc.subject | substance use treatment | en_US |
dc.subject | ADDICTION | en_US |
dc.subject | DRUGS MISUSE | en_US |
dc.subject | ADDICTION, TREATMENT | en_US |
dc.title | Slow release oral morphine versus methadone for the treatment of opioid use disorder. | en_US |
dc.type | Article | en_US |
dc.source.journaltitle | BMJ open | |
refterms.dateFOA | 2019-04-23T14:22:46Z |